Bibasilar rales were heard, but cardiac examination was unremarkable. Diminished bowel sounds and mild, diffuse, epigastric tenderness were noted. A non-blanching petechial rash containing a few pustules was noted on his abdomen. Stool did not contain occult blood. The chest radiograph taken on admission showed bilateral pulmonary infiltrates (Fig. 1 B) . DR DR. ROBERT BALTIMORE (Associate Professor ofPediatrics and Epidemiology): While bacterial pneumonias commonly infect neutropenic patients, the diffuse nature of these infiltrates makes a bacterial pneumonia less likely. This pattern is more suggestive of Pneumocystis carinii pneumonia [1 ] . In addition, lymphoma patients can develop diffuse infiltrates as a result of cytomegalovirus or Herpes zoster infections. DR. GRECO: Legionella pneumonia has also been described in this setting and deserves consideration. Mycoplasma pneumoniae is not a common cause of pneumonia in compromised hosts, but the diffuse pattern makes it worth considering. Both possibilities should be covered by including erythromycin in any empiric antibiotic coverage used while awaiting results of diagnostic tests. DR. JOHN MELLORS (Assistant Professor ofMedicine): Fungal infections have not been commented upon. Most commonly Candida, and Aspergillus, but also Mucor species, are recognized causes of fungal pneumonia in neutropenic patients [2] . Usually, Aspergillus pneumonia presents as wedge-shaped infiltrates; however, diffuse infiltrates are possible. Diagnosis of these entities might require bronchoscopy or an open-lung biopsy, but I would like to know the results of a sputum Gram stain first. DR. BERENSON: Endotracheal suctioning yielded modest amounts of blood-tinged pulmonary secretions. Occasional inflammatory cells were seen scattered among some larger unidentifiable Gram-variable objects, thought at first to represent mucous plugs. Acid-fast and potassium hydroxide preparations were not helpful. The patient was started empirically on antibiotics which included mezlocillin, an aminoglycoside, erythromycin, and trimethoprim-sulfamethoxazole to cover the range of clinical possibilities raised thus far in our discussion. Sputum was sent for Legionella direct fluorescent antibody staining, viral cultures, bacterial cultures, and both acid-fast and silver stains; however, a wet mount of sputum revealed the material shown in Fig. 2 . These objects were best seen under low power. They were clearly mobile and readily identified as filariform larvae of the nematode, Strongyloides stercoralis. DR. BIA: At this point, the previous sputum Gram stain was re-evaluated. Under low power, the large Gram-variable objects seen in the sample were recognized as filariform larvae (Fig. 3) careful low-power evaluation of this specimen been done, the organisms might have been identified on Gram stain. The utility of Gram stains for diagnosis of pulmonary strongyloidiasis has recently been reported [3] . Still, their appearance and motility makes their identification on a wet preparation of sputum somewhat easier.
The absence of peripheral eosinophilia should not preclude this diagnosis. It is taught that disseminated strongyloidiasis, and other parasitic infections, commonly present with eosinophilia. In fact, even patients with overwhelming disseminated strongyloidiasis who are not neutropenic often demonstrate eosinopenia [4] . DR. BERENSON: An interesting laboratory finding was noted by the lab technicians responsible for working on the patient's sputum culture. The growth pattern of Staphylococcus aureus in the culture seemed to follow tiny serpiginous tracks caused by movement of the larvae through the agar, a laboratory phenomenon recently reported by others [5, 6] .
Histological examination of skin biopsies was largely unremarkable; however, in a few sections, larvae were visible near dermal blood vessels (Fig. 4) begun on thiabendazole, 3 grams/day, via a nasogastric tube. Antibacterial coverage with mezlocillin and an aminoglycoside agent was continued. DR. MELLORS: Although a clear-cut bacterial infection was not demonstrated, it would be appropriate to maintain coverage for enteric organisms under these circumstances. In disseminated strongyloidiasis, enteric flora may reach the circulation by larval disruption of the bowel wall, or possibly by being "piggy-backed" across the gut on or within the migrating larvae. Hematogenous spread of bacteria can result in systemic bacterial infection such as pneumonia or Gram-negative bacillary meningitis [7] . DR. BERENSON: In fact, on the ninth day of hospitalization, he became more lethargic, and meningismus was present. A repeat lumbar puncture revealed cloudy cerebrospinal fluid with 480 red blood cells/,ul and 220 white blood cells/,ul (99 percent polymorphonuclear leukocytes). Protein and glucose concentrations remained normal; Gram stain, cryptococcal antigen determination, and India ink preparation were negative. Cultures yielded no growth. As Dr. Mellors has suggested, a partially treated meningitis of enteric origin was suspected, although cases of central nervous system strongyloidiasis have also been reported [8] . After several days of therapy with parenteral cefotaxime, 12 grams/day, cerebrospinal fluid pleocytosis resolved.
Partial ileus and large gastric residual volumes made administration of thiabendazole difficult, interrupting therapy. As the ileus improved, stool specimens showed enormous numbers of filariform larvae (Fig. 5) . Therapy with thiabendazole was continued over 25 days, until stool and sputum specimens were free of larvae.
During therapy, bilirubin and transaminase levels rose. Possible causes included thiabendazole toxicity, recurrent lymphoma, or hepatic larval infiltration. Rapidly worsening lymphadenopathy represented failure to induce remission of the underlying lymphoma. Further attempts at chemotherapy were considered unwise. Despite improvement of his parasitic infection, he succumbed to his malignancy after six weeks of hospitalization. A post-mortem examination was not performed. become invasive filariform larvae, which can penetrate the skin of humans to cause local cutaneous lesions, called larvae currens. Larvae then enter the lymphatic system and travel through veins to the right heart and lungs, where they pentrate into alveolar spaces. They are coughed up and swallowed, arriving at the duodenum and proximal jejunum. Filariform larvae than burrow into gut mucosa, where they develop into adults. Each female lays about 40 eggs per day. Ova then hatch into rhabditiform larvae, which are expelled with feces [4] . DR. BIA: In contrast to other nematode infections such as hookworm, one almost never finds S. stercoralis ova in the stool of patients with strongyloidiasis. One finds larvae instead. Finding filariform larvae in feces is one means of distinguishing between Strongyloides stercoralis infections and those caused by other nematodes [9] . If, however, a stool sample contains hookworm ova and sits for a period of time before being examined, the-ova can hatch. The larvae are difficult to distinguish from Strongyloides larvae, which have a somewhat shorter buccal cavity than do hookworm larvae (Fig. 5 ).
DR. BERENSON: If filariform larvae actually develop within the gut, they may reinvade it or penetrate the perianal skin to reinfect the same host in a process called autoinfection. Occasionally, a large number of larvae become invasive and produce a heavy nematode burden for the infected host. This is referred to as the "hyperinfection syndrome." It may include gastrointestinal problems such as nausea, vomiting, and diarrhea, and respiratory complaints such as wheezing and hemoptysis [7] .
Scowden et al. distinguish this from "disseminated strongyloidiasis," in which autoinfection is profound and large numbers of filariform larvae disseminate to many organs including liver, central nervous system, heart, lymph nodes, and kidneys. Both brain and meningeal involvement have been documented. Hepatic invasion, while unusual, is suggested by elevations of bilirubin and/or alkaline phosphatase [4] .
Both of these syndromes overlap considerably, each predisposing to bacteremia caused by enteric organisms. The lungs and meninges are sites of metastatic bacterial infections. Damage to intestinal lymphatics causes bowel edema, malabsorption, and ileus, making therapy of this illness with the currently available oral medication (thiabendazole) somewhat difficult.
About half of all patients with intestinal strongyloidiasis have no symptoms referable to the infection. Most of the remainder have only vague or mild gastrointestinal complaints. Patients with intact cell-mediated immunity do not progress to develop either dissemination or hyperinfection. Many conditions predispose to disseminated strongyloidiasis, including lymphomas, treated leukemias, renal transplantation, systemic lupus erythematosus, and nephrotic syndrome. Depressed cell-mediated immunity may also result from alcoholism, chronic renal failure, malnutrition, and carcinomas, in addition to chemotherapeutic agents which depress cell-mediated immunity [4, 10] .
During autoinfection, transformation from rhabditiform to filariform larvae occurs in the gut. Corticosteroids may encourage penetration of the gut wall by reducing local inflammation [4] . In addition, autoinfection is enhanced by azathioprine and cyclophosphamide. While it has been assumed that cyclosporine A might produce a similar predisposition, experimental evidence in rats suggests that it might actually protect been noted to have lower serum IgG levels and lower eosinophil counts than their asymptomatic counterparts [12] . In another study, immunosuppressed patients with strongyloidiasis, including some with disseminated disease, all had elevated IgG levels. Hyperinfected patients had lower IgE levels, however, as well as lower eosinophil counts than did non-hyperinfected patients. While not conclusive, a possible protective role for IgE and eosinophils is suggested [13] .
Current therapy for uncomplicated intestinal strongyloidiasis is a two-day course of thiabendazole (25 mg/kg twice a day for two days; maximum, 3 g/day), which is given orally. It is the only recommended medication for disseminated disease. Cambendazole, a thiabendazole derivative, may be superior for intestinal strongyloidiasis [14] , but it has not been evaluated for efficacy against disseminated disease and is not readily available in the U.S. The duration of therapy for disseminated disease is not at all clear, but a minimum of five days' therapy is suggested. Repeated stool examinations are probably the best parameter of successful therapy. One should remove, if possible, those factors responsible for compromising cell-mediated immunity, such as immunosuppressive drugs.
The complicated course followed by our patient clearly illustrates several of the issues discussed. He manifested both the hyperinfection state and disseminated strongyloidiasis and probably suffered from enteric bacteremia with bacterial seeding of the meninges. The latter seems more likely than meningeal infection by nematodes since cerebrospinal fluid pleocytosis rapidly resolved with antibacterial therapy. His elevated serum bilirubin and transaminase, with normal alkaline phosphatase levels, is uncharacteristic of hepatic infection by nematodes.
Exposure to S. stercoralis larvae need not have been in the recent past. Laboratory evaluations performed in veterans of World War II have demonstrated persistent strongyloidiasis acquired during their 1940s military service in southeast Asia [15, 16] . This case dictates a need to search exhaustively for intestinal evidence of strongyloidiasis in asymptomatic patients from endemic areas, particularly if eosinophilia exists, prior to institution of immunosuppressive therapy.
